Rare
lephants
Screener
Toggle theme
DexCom, Inc.
DXCM
·
Healthcare, Medical Devices, United States
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
Total Cash from Operations:
$2.00B
Line Item
Value
% of Total
Stock Repurchases
$500.0M
25.0%
Other Financing
$1.19B
59.4%
Net Cash Flow
$311.8M
15.6%
Download CSV
